Literature DB >> 31190081

[Hyperthermic intraperitoneal chemotherapy].

H Leebmann1, P Piso2.   

Abstract

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are recognized as the standard of care for selected patients with peritoneal malignancies. A complete macroscopic cytoreduction is the basis for a successful multimodal treatment. The significance of intraperitoneal chemotherapy is still under discussion. This review explains the principles and the value of HIPEC within the multimodal treatment context.

Entities:  

Keywords:  Cytoreductive Surgery; Hyperthermia; Morbidity; Mortality; Perfusion

Mesh：

Year:  2019        PMID： 31190081     DOI： 10.1007/s00104-019-0982-5

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


  43 in total

1.  Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a Nationally Funded Peritonectomy Center.

Authors:  Tristan D Yan; Matthew Links; Sal Fransi; Theresa Jacques; Deborah Black; Vanessa Saunders; David L Morris
Journal:  Ann Surg Oncol       Date:  2007-04-27       Impact factor: 5.344

2.  Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution.

Authors:  D Elias; M Bonnay; J M Puizillou; S Antoun; S Demirdjian; Otmany A El; J P Pignon; L Drouard-Troalen; J F Ouellet; M Ducreux
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

3.  Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model.

Authors:  J O W Pelz; J Doerfer; M Decker; A Dimmler; W Hohenberger; T Meyer
Journal:  Int J Colorectal Dis       Date:  2007-01-24       Impact factor: 2.571

4.  Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis.

Authors:  Dominique Elias; Bruno Raynard; Valérie Boige; Agnes Laplanche; George Estphan; David Malka; Marc Pocard
Journal:  J Surg Oncol       Date:  2005-06-15       Impact factor: 3.454

Review 5.  For the clinical application of thermochemotherapy given at mild temperatures.

Authors:  M Urano; M Kuroda; Y Nishimura
Journal:  Int J Hyperthermia       Date:  1999 Mar-Apr       Impact factor: 3.914

Review 6.  Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy.

Authors:  Paul H Sugarbaker; Jorge Torres Mora; Pablo Carmignani; O Anthony Stuart; Dal Yoo
Journal:  Oncologist       Date:  2005-02

7.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

Review 8.  Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents.

Authors:  Robert P Sticca; Brian W Dach
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

9.  Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.

Authors:  Dominique Elias; Jean-Robert Delperro; Lucas Sideris; Ellen Benhamou; Marc Pocard; Olivier Baton; Marc Giovannini; Philippe Lasser
Journal:  Ann Surg Oncol       Date:  2004-05       Impact factor: 5.344

10.  Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.

Authors:  Joerg O W Pelz; J Doerfer; A Dimmler; W Hohenberger; T Meyer
Journal:  BMC Cancer       Date:  2006-06-22       Impact factor: 4.430
View more
  3 in total

Review 1.  Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).

Authors:  Giorgi Nadiradze; Philipp Horvath; Yaroslav Sautkin; Rami Archid; Frank-Jürgen Weinreich; Alfred Königsrainer; Marc A Reymond
Journal:  Cancers (Basel)       Date:  2019-12-20       Impact factor: 6.639

2.  Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites.

Authors:  Jie Jiao; Chengzhen Li; Guanying Yu; Lei Zhang; Xiaoyan Shi; Jingdu Yan; Houjun Zhang; Peiming Guo
Journal:  World J Surg Oncol       Date:  2020-07-22       Impact factor: 2.754

3.  Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC).

Authors:  C Bachmann; I Sautkin; G Nadiradze; R Archid; F J Weinreich; A Königsrainer; M A Reymond
Journal:  Surg Endosc       Date:  2021-06-10       Impact factor: 4.584
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.